Sentien is restoring balance to the immune system by enabling sustained, dynamic secreting of therapeutic molecules for systemic inflammation.
Location: United States, Massachusetts, Lexington
Total raised: $12M
Investors 2
Date | Name | Website |
- | Mission Bi... | missionbio... |
- | Chiesi Ven... | chiesivent... |
Funding Rounds 1
Date | Series | Amount | Investors |
04.04.2017 | Series A | $12M | - |
Mentions in press and media 4
Date | Title | Description | Source |
02.09.2021 | Sentien Biotechnologies Partners with BARDA to Evaluate High... | LEXINGTON, Mass. (PRWEB) September 02, 2021 Sentien Biotechnologies, Inc., a clinical-stage biotech... | prweb.com/... |
30.03.2021 | Sentien Biotechnologies Completes Enrollment of First Cohort... | LEXINGTON , Mass. (PRWEB) March 30, 2021 Sentien Biotechnologies, Inc., a clinical-stage biotechnol... | prweb.com/... |
04.04.2017 | Sentien Biotechnologies Raises $12M in Series A Funding | Sentien Biotechnologies, Inc., a Cambridge, MA-based clinical-stage biotechnology company developing... | finsmes.co... |
07.08.2015 | Sentien Biotechnologies Raises Series A Funding Round | Sentien Biotechnologies, Inc., a Medford, MA-based regenerative medicine company developing cell bas... | finsmes.co... |